RYSTIGGO
RYSTIGGO

ONWARD wants to hear from you.

TAKE THE SURVEY

heart
WELCOME TO ONWARD4U

ONWARD® is a personalized support experience built to help you through every step of your prescribed UCB treatment. ONWARD4U gives you access to important information and resources related to your RYSTIGGO® treatment, including:

WHAT IS RYSTIGGO?

RYSTIGGO® (rozanolixizumab-noli) is indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who test positive for anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibodies.

STAY INFORMED

We have your contact information, but if there's a better way to reach you or if your preferences have changed, please update your details below. This won't affect any current communications from your ONWARD Care Coordinator.

I am a:*

*Indicates required fields

By providing your phone number above, you agree to receive text messages from UCB ONWARD for patient support. Message and data rates may apply. Message frequency will vary based on need. Text “HELP” to 844669 for help. Text “STOP” to 844669 to cancel. If you have questions, call 1-844-669-2731 (1-844-ONWARD1). For more information on how UCB will use your information, please view our privacy policy at www.ucb-usa.com/policy and our text messaging terms and conditions at www.ucbONWARD.com/Text-Terms-Conditions.

By providing your information above, you acknowledge you are a U.S. resident aged 18 or older and give UCB and its business partners permission to send you information or contact you and/or your healthcare provider regarding your disease as well as information on other related treatments, products and services, and for marketing and informational purposes by phone, email, or mail. You understand that UCB or its business partners will not sell your name, address, email address, or any other information to another party for their own marketing use.